Yahoo Web Search

Search results

1. • 

     Abbott (ABT) FreeStyle Libre 2 Gets Reimbursement in France

     Zacks via Yahoo Finance· 10 months ago

     Abbott Laboratories ABT recently announced that the FreeStyle Libre 2 system's reimbursement...

2. • 

     Abbott (ABT) Gets FDA Clearance for FreeStyle Libre 3 Reader

     Zacks via Yahoo Finance· 1 year ago

     Abbott Laboratories ABT recently announced the FDA clearance of a standalone reader for its...

3. • 

     Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices

     Investor's Business Daily· 1 year ago

     Dexcom stock popped Thursday after the Centers for Medicare and Medicaid Services said it would...

4. • 

     Diabetes tech firms focusing on Type 2 patients

     MedTech Dive via Yahoo Finance· 5 months ago

     Leaders from Abbott, Dexcom, Tandem and Insulet expect Type 2 uptake of their insulin pumps and CGMs to accelerate as coverage improves and new devices...

5. • 

     2 Healthcare Stocks That Could Make You Richer

     Motley Fool· 7 months ago

     There are many ways one can become richer, from trying to buy a winning lottery ticket to pouncing on some get-rich-quick scheme. Unfortunately, none of...

6. • 

     2 Reasons to Buy DexCom, and 1 Reason to Sell

     Motley Fool· 1 year ago

     Now, investors want to know whether DexCom can continue riding that wave for a while -- and there are good reasons why it might. DexCom develops...

7. • 

     Better Buy: Abbott Laboratories or DexCom Stock?

     Motley Fool· 1 year ago

     According to MarketStudyReport, a market research firm, the global diabetes care devices market was $23.3 billion in 2022 and is projected to reach $32.7...

8. • 

     Which Healthcare Stock Is a Better Pick in 2023?

     InvestorPlace via Yahoo Finance· 1 year ago

     Investor sentiment has improved this year on expectations of less-aggressive interest rate hikes by the Federal Reserve to tame inflation. However, the...